Serum says will raise monthly production to 10 crore doses by August, Bharat Biotech promises 7.8 crore

IndiaTimes Thursday, 13 May 2021

You Might Like

💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Brazil's Anvisa provisionally suspends authorisation for exceptional import of 4 million Covaxin doses

After closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..

After suspending Covaxin clinical trials, Brazil closes EUA request

After suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..

Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programme

Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation..

Related news from verified sources

Media reports alleging Centre hasn't placed any fresh order for Covid-19 vaccines incorrect: Health ministry

"The news reports suggest that the last order placed with the two vaccine makers (100 million doses with SII and 20 million doses with Bharat Biotech) was in...

Covaxin puzzle: 6 crore shots ready, 2 crore given. Where are the rest?

The mismatch between reported production numbers of Covid vaccines in India and the level of daily vaccination seems particularly acute in the case of Covaxin....

Serum, Bharat Biotech got advance of Rs 2,500 crore for 16 crore doses, says government

The government on Monday said it had paid an advance of over Rs 2,500 crore to Serum Institute of India and Bharat Biotech for supply of 16 crore doses of Covid...
IndiaTimes Also reported by •Zee News